Infinity Reports Updated Phase 1 Data of IPI-145 in Indolent Non-Hodgkin … – Business Wire (press release)
Infinity Reports Updated Phase 1 Data of IPI-145 in Indolent Non-Hodgkin …Business Wire (press release)Infinity is currently enrolling patients in DYNAMO, a Phase 2 study evaluating the safety and efficacy of IPI-145 in approximately 120 patients wit…
